Beren
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2101 Corporate Center Dr, Thousand Oaks,...Website
www.berentx.comRevenue
$26.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Beren
Beren Therapeutics P.B.C. is a founder-led biotechnology company focused on the discovery, development, and commercialization of cyclodextrin-based therapies for diseases associated with impaired cholesterol trafficking. The company is dedicated to advancing innovative treatments for rare and underserved conditions while maintaining a patient-centered approach that integrates the perspectives of patients, caregivers, clinicians, and healthcare systems throughout the development process. Through its research, clinical development activities, and support initiatives, Beren Therapeutics aims to improve access to meaningful therapies and deliver long-term benefits to patient communities. Headquartered in Thousand Oaks, the company emphasizes innovation, collaboration, and equitable access to treatment.Explore more
Beren Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Beren your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Beren has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Beren
Website visits: Recent activity has been detected on your website
Click to see if Beren had a recent Job posting/layoffs
Check out if Beren is spiking on competitors!
Earning: See what the market has to say on Beren recently announced quarterly report
Product Launch: Get notified when Beren launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Beren has new funding data
Beren, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Beren as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Beren is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Beren is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Beren.
Beren financials insights
Gather financial insights about Beren, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Debt
$165M
Unspecified
$135M
Beren Tech Stack
A closer look at the technologies used by Beren
Beren News & Media
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch ...
THOUSAND OAKS, Calif., June 10, 2026--Beren Therapeutics P.B.C., the parent company of Mandos LLC and a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, today announced it has secured $300 million in combined financing.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Beren
Sign Up For FreeTo access detailed company insights
Beren Therapeutics P.B.C. is a founder-led biotechnology company focused on the discovery, development, and commercialization of cyclodextrin-based therapies for diseases associated with impaired cholesterol trafficking. The company is dedicated to advancing innovative treatments for rare and underserved conditions while maintaining a patient-cente... Read More
